Skip to content

Clinical trials

Completed Demyelinating Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Demyelinating Diseases Status: Completed Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20072
20091
20101
20111
20121
20154
20161
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acorda Therapeutics4
Alexion Pharmaceuticals, Inc.2
Baxalta now part of Shire1
EMD Serono1
London Health Sciences Centre1
MedImmune LLC1
Novartis Pharmaceuticals1
The Hospital for Sick Children1
University of British Columbia1
University of Calgary1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Demyelinating Diseases14
Multiple Sclerosis9
Neuromyelitis Optica4
Autoimmune Diseases3
Autoimmune Diseases of the Nervous System3
Immune System Diseases3
Multiple Sclerosis, Relapsing-Remitting3
Nervous System Diseases3
Optic Neuritis3
Recurrence3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.